1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Periodontal Disease-Pipeline Insights, 2014

SUMMARY
DelveInsight’s,“ Periodontal Disease-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Periodontal Disease. This report provides information on the therapeutic development based on the Periodontal Disease dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Periodontal Disease
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Periodontal Disease pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Periodontal Disease and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Periodontal Disease
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Periodontal Disease pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Periodontal Disease-Pipeline Insights, 2014
Table of Contents
- Periodontal Disease Overview
- Periodontal Disease Pipeline Therapeutics
- Periodontal Disease Therapeutics under Development by Companies
- Periodontal Disease Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Periodontal Disease Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Periodontal Disease Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Periodontal Disease Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Periodontal Disease - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Periodontal Disease - Discontinued Products
- Periodontal Disease - Dormant Products
- Companies Involved in Therapeutics Development for Periodontal Disease
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Periodontal Disease, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Periodontal Disease Assessment by Monotherapy Products
- Periodontal Disease Assessment by Combination Products
- Periodontal Disease Assessment by Route of Administration
- Periodontal Disease Assessment by Stage and Route of Administration
- Periodontal Disease Assessment by Molecule Type
- Periodontal Disease Assessment by Stage and Molecule Type
- Periodontal Disease Therapeutics - Discontinued Products
- Periodontal Disease Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Periodontal Disease, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Periodontal Disease Assessment by Monotherapy Products
- Periodontal Disease Assessment by Combination Products
- Periodontal Disease Assessment by Route of Administration
- Periodontal Disease Assessment by Stage and Route of Administration
- Periodontal Disease Assessment by Molecule Type
- Periodontal Disease Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Gingivitis Global Clinical Trials Review, H2, 2016

Gingivitis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by Global Data

Gingivitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Gingivitis Global Clinical Trials Review, H2, 2016" provides an overview of Gingivitis clinical trials ...

Periodontal Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Periodontal Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Periodontal Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...


Download Unlimited Documents from Trusted Public Sources

Mouth Disease Statistics in Europe and Sweden

  • January 2017
    14 pages
  • Mouth Disease  

  • Europe  

    Sweden  

View report >

Influenza Statistics in Chile

  • January 2017
    11 pages
  • Influenza  

  • Chile  

    South America  

    United States  

View report >

Infectious Disease Statistics in China

  • January 2017
    8 pages
  • Infectious Dise...  

  • China  

    Asia  

View report >

Related Market Segments :

Mouth Disease

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.